Ameriprise’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Sell
125,882
-512,152
-80% -$43.4M ﹤0.01% 1965
2026
Q1
$53.3M Sell
638,034
-35,157
-5% -$2.88M 0.01% 840
2025
Q4
$61.7M Sell
673,191
-17,378
-3% -$1.66M 0.01% 767
2025
Q3
$65.4M Sell
690,569
-41,865
-6% -$3.94M 0.02% 749
2025
Q2
$76.7M Buy
732,434
+62,495
+9% +$5.92M 0.02% 663
2025
Q1
$59.2M Buy
669,939
+399,897
+148% +$41M 0.02% 755
2024
Q4
$25.9M Buy
270,042
+97,329
+56% +$9.07M 0.01% 1178
2024
Q3
$14.1M Sell
172,713
-27,056
-14% -$2.09M ﹤0.01% 1535
2024
Q2
$17.2M Sell
199,769
-23,143
-10% -$1.87M ﹤0.01% 1372
2024
Q1
$18.2M Sell
222,912
-5,922
-3% -$462K 0.01% 1359
2023
Q4
$15.2M Buy
228,834
+10,268
+5% +$712K ﹤0.01% 1446
2023
Q3
$16M Sell
218,566
-910
-0.4% -$61.5K 0.01% 1371
2023
Q2
$13.9M Sell
219,476
-6,723
-3% -$390K ﹤0.01% 1513
2023
Q1
$13.3M Sell
226,199
-36,146
-14% -$2.2M ﹤0.01% 1555
2022
Q4
$16.2M Buy
262,345
+16,201
+7% +$1.09M 0.01% 1345
2022
Q3
$16.5M Buy
246,144
+34,262
+16% +$2.17M 0.01% 1301
2022
Q2
$13M Buy
211,882
+8,799
+4% +$564K ﹤0.01% 1527
2022
Q1
$13.7M Buy
203,083
+3,045
+2% +$164K ﹤0.01% 1639
2021
Q4
$8.85M Sell
200,038
-915,577
-82% -$53.3M ﹤0.01% 2066
2021
Q3
$72.3M Sell
1,115,615
-158,225
-12% -$11M 0.02% 616
2021
Q2
$103M Sell
1,273,840
-102,687
-7% -$7.82M 0.03% 522
2021
Q1
$93.6M Buy
1,376,527
+293,149
+27% +$23M 0.03% 531
2020
Q4
$75.5M Sell
1,083,378
-62,694
-5% -$3.9M 0.03% 568
2020
Q3
$58.9M Buy
1,146,072
+136,119
+13% +$7.48M 0.02% 581
2020
Q2
$59.3M Buy
1,009,953
+36,414
+4% +$2.01M 0.03% 555
2020
Q1
$49.3M Buy
973,539
+178,664
+22% +$11.9M 0.03% 552
2019
Q4
$58.9M Buy
794,875
+344,886
+77% +$21.5M 0.02% 627
2019
Q3
$25.7M Sell
449,989
-23,782
-5% -$1.58M 0.01% 971
2019
Q2
$31M Sell
473,771
-380,903
-45% -$26.5M 0.01% 894
2019
Q1
$63.2M Buy
854,674
+268,841
+46% +$18.9M 0.03% 558
2018
Q4
$34.9M Sell
585,833
-83,161
-12% -$6.7M 0.02% 765
2018
Q3
$63.2M Buy
668,994
+16,802
+3% +$1.45M 0.02% 632
2018
Q2
$49M Buy
652,192
+5,469
+0.8% +$393K 0.02% 686
2018
Q1
$39.2M Buy
646,723
+233,825
+57% +$12.7M 0.02% 770
2017
Q4
$19.3M Sell
412,898
-13,812
-3% -$684K 0.01% 1092
2017
Q3
$21.6M Buy
426,710
+51,992
+14% +$2.42M 0.01% 991
2017
Q2
$18.7M Buy
374,718
+15,137
+4% +$708K 0.01% 1068
2017
Q1
$15.3M Sell
359,581
-107,476
-23% -$4.76M 0.01% 1209
2016
Q4
$18.9M Buy
467,057
+137,238
+42% +$5.3M 0.01% 1029
2016
Q3
$12.5M Buy
329,819
+18,264
+6% +$579K 0.01% 1271
2016
Q2
$9.47M Sell
311,555
-28,866
-8% -$758K 0.01% 1438
2016
Q1
$8.4M Buy
340,421
+25,532
+8% +$547K 0.01% 1569
2015
Q4
$7.89M Sell
314,889
-63,261
-17% -$1.94M ﹤0.01% 1639
2015
Q3
$11.2M Sell
378,150
-38,032
-9% -$1.2M 0.01% 1379
2015
Q2
$13.3M Buy
416,182
+89,153
+27% +$2.39M 0.01% 1345
2015
Q1
$8.17M Buy
327,029
+71,639
+28% +$1.55M ﹤0.01% 1727
2014
Q4
$6.5M Sell
255,390
-32,915
-11% -$714K ﹤0.01% 1876
2014
Q3
$5.28M Buy
+288,305
New +$5.53M ﹤0.01% 1993

Other funds holding HQY

Ameriprise's HQY Position: Q2 2026 in Review

Ameriprise reduced its HealthEquity (HQY) stake by 80% in Q2 2026, selling an estimated $43.4M and leaving 125,882 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

Ameriprise first reported a position in HQY in Q3 2014 and has held it in 48 quarters since. The position peaked at $103M in Q2 2021. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Ameriprise held 125,882 shares of HealthEquity worth $11.4M as of Q2 2026.
  • Ameriprise sold 512,152 HealthEquity shares in Q2 2026, an estimated $43.4M.
  • HealthEquity made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1965 holding.
  • Ameriprise first reported a position in HealthEquity in Q3 2014 and has held it in 48 quarters since.
  • Ameriprise's HealthEquity position peaked at $103M in Q2 2021.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.